|
1OC0
plasminogen activator inhibitor-1 complex with somatomedin B domain of vitronectin
Deposited 2003-02-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
20–70(51 aa)
Fragment:SOMATOMEDIN B, RESIDUES 20-70
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.4;10MM NAOAC, 50MM NACL, 2-9% PEG12000,25% PEG400, 50MM HEPES, PH 7.4
|
Resolution 2.28 Å
R-free 0.252
|
|
1S4G
Somatomedin-B Domain of human plasma vitronectin.
Deposited 2004-01-16
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
20–70(51 aa)
Fragment:Somatomedin B
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 4.4;298 K;Ionic strength (raw mmCIF value) low
NMR sample composition
Isolated from human plasma vitronectin by CNBr cleavage
|
Resolution not provided
|
|
1SSU
Structural and biochemical evidence for disulfide bond heterogeneity in active forms of the somatomedin B domain of human vitronectin
Deposited 2004-03-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
20–70(51 aa)
Fragment:somatomedin B domain of human vitronectin
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;293 K;Ionic strength (raw mmCIF value) 180 mM;Pressure 1
NMR measurement conditions
pH 7.5;293 K;Ionic strength (raw mmCIF value) 180 mM;Pressure 1
NMR sample composition
N15-labeled protein
20 mM sodium phosphate pH 7.5 | 90% H2O/10% D2O
NMR sample composition
unlabeled protein
20 mM sodium phosphate pH 7.5 | 90% H2O/10% D2O
|
Resolution not provided
|
|
2JQ8
Solution structure of the Somatomedin B domain from vitronectin produced in Pichia pastoris
Deposited 2007-05-30
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
20–66(47 aa)
Fragment:sequence database residues 20-66
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;298 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR sample composition
0.4 mM [U-99% 13C; U-99% 15N] SMB, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.7 mM SMB, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
3BT1
Structure of urokinase receptor, urokinase and vitronectin complex
Deposited 2007-12-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
21–60(40 aa)
Fragment:sometomedin-B domain
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7.5;295 K;12% PEG 3350, 50mM HEPES pH 7.5, MICRODIALYSIS, temperature 295K
|
Resolution 2.80 Å
R-free 0.308
|
|
3BT2
Structure of urokinase receptor, urokinase and vitronectin complex
Deposited 2007-12-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
21–60(40 aa)
Fragment:sometomedin-B domain
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7.5;295 K;8% PEG 4000, 2.5% ethanol, 0.05% sodium azide, 50mM cacodylate pH 6.5, pH 7.5, MICRODIALYSIS, temperature 295K
|
Resolution 2.50 Å
R-free 0.272
|
|
3BT2
Structure of urokinase receptor, urokinase and vitronectin complex
Deposited 2007-12-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
21–60(40 aa)
Fragment:sometomedin-B domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7.5;295 K;8% PEG 4000, 2.5% ethanol, 0.05% sodium azide, 50mM cacodylate pH 6.5, pH 7.5, MICRODIALYSIS, temperature 295K
|
Resolution 2.50 Å
R-free 0.272
|
|
4K24
Structure of anti-uPAR Fab ATN-658 in complex with uPAR
Deposited 2013-04-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
21–60(40 aa)
Fragment:UNP residues 21-60
|
Not recorded
|
MAN alpha-D-mannopyranose × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;0.1M HEPES pH 7.5, 55%(v/v) Tacsimate, 2%(v/v) 2-methyl-1,3-propanediol, vapor diffusion, sitting drop, temperature 295K
|
Resolution 4.50 Å
R-free 0.275
|
|
6O5E
Crystal structure of the Vitronectin hemopexin-like domain
Deposited 2019-03-01
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
154–285(132 aa)
Fragment:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
Chain A
324–354(31 aa)
Fragment:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
Chain A
435–474(40 aa)
Fragment:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
|
Mutation:C180S, C215S
Mutation:C180S, C215S
Mutation:C180S, C215S
|
NA SODIUM ION × 2
CL CHLORIDE ION × 1
SO4 SULFATE ION × 1
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;1 uL protein solution + 1 uL precipitate solution [0.09 M imidazole/MES, pH 6.5, 27 mM sodium nitrate, 27 mM sodium phosphate dibasic, 27 mM ammonium sulfate, 11.25% v/v MPD, 11.25% w/v PEG1000, 11.25% w/v PEG3350, 3% w/v D-(+)-trehalose]
|
Resolution 1.90 Å
R-free 0.210
|
|
6O5E
Crystal structure of the Vitronectin hemopexin-like domain
Deposited 2019-03-01
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
154–285(132 aa)
Fragment:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
Chain B
324–354(31 aa)
Fragment:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
Chain B
435–474(40 aa)
Fragment:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
|
Mutation:C180S, C215S
Mutation:C180S, C215S
Mutation:C180S, C215S
|
NA SODIUM ION × 2
CL CHLORIDE ION × 1
SO4 SULFATE ION × 2
NO3 NITRATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;1 uL protein solution + 1 uL precipitate solution [0.09 M imidazole/MES, pH 6.5, 27 mM sodium nitrate, 27 mM sodium phosphate dibasic, 27 mM ammonium sulfate, 11.25% v/v MPD, 11.25% w/v PEG1000, 11.25% w/v PEG3350, 3% w/v D-(+)-trehalose]
|
Resolution 1.90 Å
R-free 0.210
|